April 19, 2014
Intellipharmaceutics International Inc. (Nasdaq: IPCI) today announced that the Food and Drug Administration has accepted for filing its abbreviated new drug application for a generic version of Protonix®. Protonix inhibits gastric...(read more)
Intellipharmaceutics (IPCI) Company Overview
There is no analysis for IPCI yet. But you can go to Wikinvest to help create one!